Lyme Disease Diagnostics Market : Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Jun 2021| TMR2370A| Transparency

Report Highlights

Lyme Disease Diagnostics Market – Scope of Report

TMR’s report on the global Lyme disease diagnostic market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global Lyme disease diagnostic market for the period of 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Lyme disease diagnostic market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Lyme disease diagnostic market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the Lyme disease diagnostic market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global Lyme disease diagnostic market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Lyme disease diagnostic market.

The report delves into the competitive landscape of the global Lyme disease diagnostic market. Key players operating in the global Lyme disease diagnostic market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Lyme disease diagnostic market profiled in this report.

Key Questions Answered in Lyme Disease Diagnostics Market Report

  • What is the sales/revenue generated by Lyme disease diagnostics across all regions during the forecast period?
  • What are the opportunities in the global Lyme disease diagnostic market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which diagnostic test segment is expected to generate the highest revenue globally in 2031? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Lyme Disease Diagnostics Market – Research Objectives and Research Approach

The comprehensive report on the global Lyme disease diagnostic market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller one. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Lyme disease diagnostic market in terms of diagnostic test, sample, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2031 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Lyme disease diagnostic market.

  • Table 1 : Global Lyme Disease Diagnostics Market
  • Table 2 : 2019A Total Revenue
  • Table 3 : 2031F Total Revenue
  • Table 4 : Executive Summary
  • Table 5 : Market Overview
  • Table 6 : Key Industry Events
  • Table 7 : Impact of COVID-19 Pandemic
  • Table 8 : Global Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Test, 2017-2031
  • Table 9 : Global Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Serological Test, 2017-2031
  • Table 10 : Global Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Sample, 2017-2031
  • Table 11 : Global Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 12 : Global Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Region , 2017-2031
  • Table 13 : North America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Test, 2017-2031
  • Table 14 : North America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Serological Test, 2017-2031
  • Table 15 : North America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Sample, 2017-2031
  • Table 16 : North America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17 : North America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 18 : Europe Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Test, 2017-2031
  • Table 19 : Europe Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Serological Test, 2018
  • Table 20 : Europe Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Sample, 2017-2031
  • Table 21 : Europe Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 22 : Europe Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-segment, 2017-2031
  • Table 23 : Asia Pacific Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Test, 2017-2031
  • Table 24 : Asia Pacific Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Serological Test, 2017-2031
  • Table 25 : Asia Pacific Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Sample, 2017-2031
  • Table 26 : Asia Pacific Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 27 : Asia Pacific Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-segment, 2017-2031
  • Table 28 : Latin America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Test, 2017-2031
  • Table 29 : Latin America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Serological Test, 2017-2031
  • Table 30 : Latin America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Sample, 2017-2031
  • Table 31 : Latin America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 32 : Latin America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 33 : Middle East & Africa Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Test, 2017-2031
  • Table 34 : Middle East & Africa Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Serological Test, 2017-2031
  • Table 35 : Middle East & Africa Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Sample, 2017-2031
  • Table 36 : Middle East & Africa Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 37 : Middle East & Africa Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-segment, 2017-2031
  • Table 38 : T2 Biosystems, Inc. Business Overview
  • Table 39 : T2 Biosystems, Inc. Strategic Overview
  • Table 40 : QIAGEN. Business Overview
  • Table 41 : QIAGEN. Strategic Overview
  • Table 42 : DiaSorin S.p.A. Business Overview
  • Table 43 : DiaSorin S.p.A. Strategic Overview
  • Table 44 : Bio-Rad Laboratories Business Overview
  • Table 45 : Bio-Rad Laboratories Strategic Overview
  • Table 46 : Thermo Fisher Scientific, Inc. Business Overview
  • Table 47 : Thermo Fisher Scientific, Inc. Strategic Overview
  • Table 48 : Trinity Biotech plc Business Overview
  • Table 49 : Trinity Biotech plc Strategic Overview
  • Table 50 : Trinity Biotech plc Business Overview
  • Table 51 : Trinity Biotech plc Strategic Overview
  • Table 52 : IGeneX, Inc. Business Overview
  • Table 53 : IGeneX, Inc. Strategic Overview
  • Table 54 : Lyme Diagnostics Ltd. Business Overview
  • Table 55 : Lyme Diagnostics Ltd. Strategic Overview
  • Table 56 : PerkinElmer, Inc. Business Overview
  • Table 57 : PerkinElmer, Inc. Strategic Overview
  • Table 58 : Oxford Immunotec plc (Boulder Diagnostics) Business Overview
  • Table 59 : Oxford Immunotec plc (Boulder Diagnostics) Strategic Overview
  • Table 60 : Cenogenics Corporation Business Overview
  • Table 61 : Cenogenics Corporation Strategic Overview
  • Table 62 : Quest Diagnostics. Business Overview
  • Table 63 : Quest Diagnostics. Strategic Overview
  • Table 64 : Ceres Nanosciences, Inc. Business Overview
  • Table 65 : Ceres Nanosciences, Inc. Strategic Overview
  • Table 66 : Galaxy Diagnostics Business Overview
  • Table 67 : Galaxy Diagnostics Strategic Overview
  • Figure 1 : % CAGR (2021-2031)
  • Figure 2 : Drivers
  • Figure 3 : Global Lyme Disease Diagnostics Market - Drivers (1)
  • Figure 4 : Global Lyme Disease Diagnostics Market - Drivers (2)
  • Figure 5 : Restraints
  • Figure 6 : Opportunities
  • Figure 7 : Lyme Disease Epidemiology
  • Figure 8 : COVID-19 Pandemics Short- / Mid- / Long-term Impact on Lyme Disease Diagnostics Market
  • Figure 9 : Introduction-Global Lyme Disease Diagnostics Market, by Diagnostic Test
  • Figure 10 : Global Lyme Disease Diagnostics Market Value Share Analysis, by Diagnostic Test, 2019 and 2031
  • Figure 11 : Global Lyme Disease Diagnostics Market Value (US$ Mn), by Serological Test, 2017-2031
  • Figure 12 : Global Lyme Disease Diagnostics Market Value (US$ Mn), by Polymerase Chain Reaction (PCR) Testing, 2017-2031
  • Figure 13 : Global Lyme Disease Diagnostics Market Value (US$ Mn), by Immunofluorescence (IFA), 2017-2031
  • Figure 14 : Global Lyme Disease Diagnostics Market Value (US$ Mn), by lymphocyte Transformation Test, 2017-2031
  • Figure 15 : Global Lyme Disease Diagnostics Market Value (US$ Mn), by Urine Antigen Testing, 2017-2031
  • Figure 16 : Global Lyme Disease Diagnostics Market Value (US$ Mn), by Others, 2017-2031
  • Figure 17 : Global Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test, 2021-2031
  • Figure 18 : Introduction - Global Lyme Disease Diagnostics Market Analysis, by Sample (1/4)
  • Figure 19 : Introduction - Global Lyme Disease Diagnostics Market Analysis, by Sample (2/4)
  • Figure 20 : Introduction - Global Lyme Disease Diagnostics Market Analysis, by Sample (3/4)
  • Figure 21 : Introduction - Global Lyme Disease Diagnostics Market Analysis, by Sample (4/4)
  • Figure 22 : Global Lyme Disease Diagnostics Market Value Share Analysis, by Sample, 2019 and 2031
  • Figure 23 : Global Lyme Disease Diagnostics Market Value (US$ Mn), by Blood, 2017-2031
  • Figure 24 : Global Lyme Disease Diagnostics Market Value (US$ Mn), by Cerebrospinal Fluid (CSF), 2017-2031
  • Figure 25 : Global Lyme Disease Diagnostics Market Value (US$ Mn), by Joint Fluid, 2017-2031
  • Figure 26 : Global Lyme Disease Diagnostics Market Value (US$ Mn), by Urine, 2017-2031
  • Figure 27 : Introduction-Global Lyme Disease Diagnostics Market Analysis, by End-user (1/4)
  • Figure 28 : Introduction-Global Lyme Disease Diagnostics Market Analysis, by End-user (2/4)
  • Figure 29 : Introduction -Global Lyme Disease Diagnostics Market Analysis, by End-user (3/4)
  • Figure 30 : Introduction -Global Lyme Disease Diagnostics Market Analysis, by End-user (4/4)
  • Figure 31 : Global Lyme Disease Diagnostics Market Value Share Analysis, by End-user, 2019 and 2031
  • Figure 32 : Global Lyme Disease Diagnostics Market Value (US$ Mn), by Hospitals, 2017-2031
  • Figure 33 : Global Lyme Disease Diagnostics Market Value (US$ Mn), by Clinical Laboratories, 2017-2031
  • Figure 34 : Global Lyme Disease Diagnostics Market Value (US$ Mn), by Physician Clinics, 2017-2031
  • Figure 35 : Global Lyme Disease Diagnostics Market Value (US$ Mn), by Others, 2017-2031
  • Figure 36 : North America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 37 : North America Lyme Disease Diagnostics Market Value Share Analysis, by Diagnostic Test, 2019 and 2031
  • Figure 38 : North America Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test, 2021-2031
  • Figure 39 : North America Lyme Disease Diagnostics Market Value Share Analysis, by Sample, 2019 and 2031
  • Figure 40 : North America Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample, 2020
  • Figure 41 : North America Lyme Disease Diagnostics Market Value Share Analysis, by End-user, 2020
  • Figure 42 : North America Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user, 2020
  • Figure 43 : Europe Lyme Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 44 : Europe Lyme Disease Diagnostics Market Value Share Analysis, by Diagnostic Test, 2019 and 2031
  • Figure 45 : Europe Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test, 2021-2031
  • Figure 46 : Europe Lyme Disease Diagnostics Market Value Share Analysis, by Sample, 2019 and 2031
  • Figure 47 : Europe Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample, 2020
  • Figure 48 : Europe Lyme Disease Diagnostics Market Value Share Analysis, by End-user, 2020
  • Figure 49 : Europe Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user, 2020
  • Figure 50 : Asia Pacific Lyme Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 51 : Asia Pacific Lyme Disease Diagnostics Market Value Share Analysis, by Diagnostic Test, 2019 and 2031
  • Figure 52 : Asia Pacific Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test, 2021-2031
  • Figure 53 : Asia Pacific Lyme Disease Diagnostics Market Value Share Analysis, by Sample, 2019 and 2031
  • Figure 54 : Asia Pacific Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample, 2020
  • Figure 55 : Asia Pacific Lyme Disease Diagnostics Market Value Share Analysis, by End-user, 2020
  • Figure 56 : Asia Pacific Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user, 2020
  • Figure 57 : Latin America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 58 : Latin America Lyme Disease Diagnostics Market Value Share Analysis, by Diagnostic Test, 2019 and 2031
  • Figure 59 : Latin America Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test, 2021-2031
  • Figure 60 : Latin America Lyme Disease Diagnostics Market Value Share Analysis, by Sample, 2019 and 2031
  • Figure 61 : Latin America Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample, 2020
  • Figure 62 : Latin America Lyme Disease Diagnostics Market Value Share Analysis, by End-user, 2020
  • Figure 63 : Latin America Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user, 2020
  • Figure 64 : Middle East & Africa Lyme Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 65 : Middle East & Africa Lyme Disease Diagnostics Market Value Share Analysis, by Diagnostic Test, 2019 and 2031
  • Figure 66 : Middle East & Africa Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test, 2021-2031
  • Figure 67 : Middle East & Africa Lyme Disease Diagnostics Market Value Share Analysis, by Sample, 2019 and 2031
  • Figure 68 : Middle East & Africa Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample, 2020
  • Figure 69 : Middle East & Africa Lyme Disease Diagnostics Market Value Share Analysis, by End-user, 2020

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS